| 0 |
MALIGNANT CRANIAL NERVE NEOPLASM |
18 |
0.6923 |
| 1 |
HUMAN ANTI-MOUSE ANTIBODY INCREASED |
1 |
0.5000 |
| 2 |
CENTRAL NERVOUS SYSTEM NEUROBLASTOMA |
1 |
0.5000 |
| 3 |
NEUROBLASTOMA RECURRENT |
89 |
0.4384 |
| 4 |
PUPILLOTONIA |
2 |
0.4000 |
| 5 |
RETRO-ORBITAL NEOPLASM |
18 |
0.3396 |
| 6 |
KIDNEY HYPERMOBILITY |
1 |
0.2000 |
| 7 |
THALAMIC MICROHAEMORRHAGE |
1 |
0.1667 |
| 8 |
NEUROBLASTOMA |
56 |
0.1462 |
| 9 |
PROTEIN ALBUMIN RATIO DECREASED |
3 |
0.1364 |
| 10 |
HUMAN ANTI-MOUSE ANTIBODY POSITIVE |
2 |
0.1176 |
| 11 |
GUT DERIVED INFECTION |
1 |
0.0909 |
| 12 |
MYXOMA |
1 |
0.0714 |
| 13 |
CENTRAL NERVOUS SYSTEM MELANOMA |
1 |
0.0625 |
| 14 |
PUNCTURE SITE ABSCESS |
1 |
0.0556 |
| 15 |
PLATELET ANISOCYTOSIS |
1 |
0.0435 |
| 16 |
CONGENITAL CENTRAL HYPOVENTILATION SYNDROME |
1 |
0.0417 |
| 17 |
BRAIN STEM MICROHAEMORRHAGE |
1 |
0.0357 |
| 18 |
RETROGRADE PORTAL VEIN FLOW |
1 |
0.0323 |
| 19 |
PLEUROPARENCHYMAL FIBROELASTOSIS |
3 |
0.0288 |
| 20 |
CITROBACTER SEPSIS |
1 |
0.0250 |
| 21 |
NEURONE-SPECIFIC ENOLASE INCREASED |
1 |
0.0233 |
| 22 |
EMOTIONAL DISORDER OF CHILDHOOD |
1 |
0.0161 |
| 23 |
CAPILLARY LEAK SYNDROME |
33 |
0.0159 |
| 24 |
CAPILLARY PERMEABILITY INCREASED |
1 |
0.0154 |
| 25 |
GANGLIONEUROMA |
1 |
0.0152 |
| 26 |
ANAPLASTIC LYMPHOMA KINASE GENE MUTATION |
1 |
0.0152 |
| 27 |
ANTITHROMBIN III DECREASED |
4 |
0.0147 |
| 28 |
PNEUMOCYSTIS TEST POSITIVE |
1 |
0.0139 |
| 29 |
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN |
1 |
0.0139 |
| 30 |
NEUROGENIC BOWEL |
3 |
0.0126 |
| 31 |
MYELITIS TRANSVERSE |
17 |
0.0121 |
| 32 |
POST PROCEDURAL HYPOTENSION |
1 |
0.0118 |
| 33 |
GROWTH DISORDER |
3 |
0.0111 |
| 34 |
ADENOVIRUS TEST POSITIVE |
1 |
0.0105 |
| 35 |
OSTEOSARCOMA METASTATIC |
1 |
0.0105 |
| 36 |
FIBRIN DEGRADATION PRODUCTS INCREASED |
3 |
0.0101 |
| 37 |
DELIRIUM FEBRILE |
1 |
0.0096 |
| 38 |
BLOOD LACTATE DEHYDROGENASE DECREASED |
3 |
0.0090 |
| 39 |
ABDOMINAL REBOUND TENDERNESS |
1 |
0.0089 |
| 40 |
CLOSTRIDIAL SEPSIS |
2 |
0.0083 |
| 41 |
BLOOD GROWTH HORMONE ABNORMAL |
1 |
0.0082 |
| 42 |
PERIPORTAL OEDEMA |
1 |
0.0080 |
| 43 |
NEUTRALISING ANTIBODIES |
1 |
0.0079 |
| 44 |
SHORT STATURE |
2 |
0.0076 |
| 45 |
DEVELOPMENTAL REGRESSION |
1 |
0.0074 |
| 46 |
GENE MUTATION IDENTIFICATION TEST POSITIVE |
3 |
0.0071 |
| 47 |
HYPOALBUMINAEMIA |
55 |
0.0071 |
| 48 |
IIIRD NERVE DISORDER |
1 |
0.0070 |
| 49 |
ENDOCARDITIS NONINFECTIVE |
1 |
0.0067 |
| 50 |
SECONDARY AMYLOIDOSIS |
1 |
0.0066 |
| 51 |
EPIPHYSES PREMATURE FUSION |
2 |
0.0066 |
| 52 |
GASTRITIS BACTERIAL |
3 |
0.0064 |
| 53 |
PNEUMOPERICARDIUM |
1 |
0.0058 |
| 54 |
ACUTE MYELOID LEUKAEMIA REFRACTORY |
1 |
0.0058 |
| 55 |
MULTISYSTEM INFLAMMATORY SYNDROME |
1 |
0.0058 |
| 56 |
TRI-IODOTHYRONINE DECREASED |
3 |
0.0057 |
| 57 |
TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT |
1 |
0.0055 |
| 58 |
METASTASES TO SPINE |
18 |
0.0054 |
| 59 |
FUNGAEMIA |
8 |
0.0051 |
| 60 |
BONE MARROW TOXICITY |
6 |
0.0051 |
| 61 |
OPTIC ATROPHY |
8 |
0.0049 |
| 62 |
RED BLOOD CELL TRANSFUSION |
2 |
0.0049 |
| 63 |
THYROXINE DECREASED |
3 |
0.0048 |
| 64 |
REFRACTORY CANCER |
1 |
0.0047 |
| 65 |
HEARING AID USER |
2 |
0.0047 |
| 66 |
CARDIAC MYXOMA |
1 |
0.0046 |
| 67 |
PNEUMATOSIS |
2 |
0.0045 |
| 68 |
CHYLOTHORAX |
3 |
0.0042 |
| 69 |
POSTICTAL PARALYSIS |
1 |
0.0041 |
| 70 |
ACCOMMODATION DISORDER |
3 |
0.0041 |
| 71 |
RESPIRATORY TRACT INFECTION FUNGAL |
2 |
0.0038 |
| 72 |
URETERIC STENOSIS |
3 |
0.0037 |
| 73 |
COOMBS TEST POSITIVE |
1 |
0.0037 |
| 74 |
AGONAL RESPIRATION |
1 |
0.0035 |
| 75 |
HUMAN HERPESVIRUS 6 ENCEPHALITIS |
1 |
0.0035 |
| 76 |
URINARY TRACT INFECTION FUNGAL |
2 |
0.0035 |
| 77 |
FIBRIN D DIMER INCREASED |
12 |
0.0034 |
| 78 |
PREMATURE MENOPAUSE |
3 |
0.0032 |
| 79 |
OTOTOXICITY |
6 |
0.0032 |
| 80 |
PUPILLARY REFLEX IMPAIRED |
6 |
0.0032 |
| 81 |
WHITE BLOOD CELLS URINE POSITIVE |
6 |
0.0032 |
| 82 |
DEVICE PROGRAMMING ERROR |
1 |
0.0032 |
| 83 |
PNEUMONIA LEGIONELLA |
5 |
0.0031 |
| 84 |
RED BLOOD CELL SCHISTOCYTES PRESENT |
1 |
0.0031 |
| 85 |
HYPERMAGNESAEMIA |
2 |
0.0031 |
| 86 |
ANTIBODY TEST POSITIVE |
5 |
0.0030 |
| 87 |
PERIPHERAL MOTOR NEUROPATHY |
4 |
0.0029 |
| 88 |
FLUID IMBALANCE |
2 |
0.0028 |
| 89 |
PORTAL VENOUS GAS |
1 |
0.0028 |
| 90 |
NERVE COMPRESSION |
25 |
0.0027 |
| 91 |
HUMAN RHINOVIRUS TEST POSITIVE |
1 |
0.0027 |
| 92 |
ANISOCORIA |
1 |
0.0026 |
| 93 |
BLOOD FIBRINOGEN DECREASED |
3 |
0.0026 |
| 94 |
PUPILS UNEQUAL |
3 |
0.0026 |
| 95 |
CAPILLARY DISORDER |
1 |
0.0026 |
| 96 |
OSTEOSARCOMA |
1 |
0.0026 |
| 97 |
INTRACRANIAL TUMOUR HAEMORRHAGE |
1 |
0.0026 |
| 98 |
ADRENAL GLAND CANCER |
1 |
0.0026 |
| 99 |
THROMBOTIC MICROANGIOPATHY |
25 |
0.0026 |
| 100 |
ATYPICAL HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0025 |
| 101 |
PRODUCT USED FOR UNKNOWN INDICATION |
3 |
0.0024 |
| 102 |
TRANSPLANTATION COMPLICATION |
1 |
0.0024 |
| 103 |
INCORRECT DRUG ADMINISTRATION RATE |
10 |
0.0023 |
| 104 |
PANCREATIC ATROPHY |
1 |
0.0023 |
| 105 |
POSTRENAL FAILURE |
1 |
0.0023 |
| 106 |
EYELID INFECTION |
1 |
0.0023 |
| 107 |
FEEDING INTOLERANCE |
1 |
0.0022 |
| 108 |
PROTEIN URINE |
2 |
0.0022 |
| 109 |
LACRIMATION DECREASED |
1 |
0.0021 |
| 110 |
PYELOCALIECTASIS |
2 |
0.0021 |
| 111 |
HYPOREFLEXIA |
4 |
0.0021 |
| 112 |
BLOOD BICARBONATE INCREASED |
1 |
0.0021 |
| 113 |
KNEE DEFORMITY |
3 |
0.0020 |
| 114 |
HYPOPERFUSION |
2 |
0.0019 |
| 115 |
PHARYNGEAL MASS |
1 |
0.0019 |
| 116 |
SCROTAL PAIN |
1 |
0.0019 |
| 117 |
BRADYPNOEA |
5 |
0.0019 |
| 118 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
4 |
0.0018 |
| 119 |
CARDIOTOXICITY |
16 |
0.0018 |
| 120 |
MYDRIASIS |
23 |
0.0018 |
| 121 |
TREATMENT DELAYED |
3 |
0.0017 |
| 122 |
TRANSAMINASES ABNORMAL |
1 |
0.0017 |
| 123 |
URINE OUTPUT DECREASED |
15 |
0.0017 |
| 124 |
FEBRILE INFECTION |
2 |
0.0017 |
| 125 |
HYPERTENSIVE ENCEPHALOPATHY |
1 |
0.0017 |
| 126 |
GRUNTING |
1 |
0.0017 |
| 127 |
PUPILLARY DISORDER |
1 |
0.0016 |
| 128 |
CATARACT SUBCAPSULAR |
1 |
0.0016 |
| 129 |
EYELID OEDEMA |
19 |
0.0016 |
| 130 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
36 |
0.0016 |
| 131 |
HYPERVOLAEMIA |
8 |
0.0016 |
| 132 |
VENOOCCLUSIVE DISEASE |
4 |
0.0016 |
| 133 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
8 |
0.0016 |
| 134 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
15 |
0.0016 |
| 135 |
ABDOMINAL COMPARTMENT SYNDROME |
1 |
0.0016 |
| 136 |
SEDATION COMPLICATION |
4 |
0.0016 |
| 137 |
ANAL INFLAMMATION |
1 |
0.0016 |
| 138 |
BODY HEIGHT BELOW NORMAL |
1 |
0.0016 |
| 139 |
PLATELET TRANSFUSION |
2 |
0.0016 |
| 140 |
TUMOUR PAIN |
2 |
0.0015 |
| 141 |
LEUKOCYTOSIS |
27 |
0.0015 |
| 142 |
HYPOPHOSPHATAEMIA |
11 |
0.0015 |
| 143 |
PARANEOPLASTIC SYNDROME |
1 |
0.0015 |
| 144 |
NEURODEVELOPMENTAL DISORDER |
1 |
0.0015 |
| 145 |
GASTROINTESTINAL TOXICITY |
7 |
0.0015 |
| 146 |
PAINFUL ERECTION |
1 |
0.0015 |
| 147 |
LIVEDO RETICULARIS |
3 |
0.0014 |
| 148 |
FACE OEDEMA |
24 |
0.0014 |
| 149 |
PULMONARY TOXICITY |
10 |
0.0014 |
| 150 |
HEMIANOPIA HOMONYMOUS |
1 |
0.0014 |
| 151 |
HYPOXIA |
48 |
0.0014 |
| 152 |
METASTASES TO LIVER |
23 |
0.0013 |
| 153 |
MYELITIS |
2 |
0.0013 |
| 154 |
METAPNEUMOVIRUS INFECTION |
1 |
0.0013 |
| 155 |
BLOOD FIBRINOGEN INCREASED |
1 |
0.0013 |
| 156 |
ALTERED VISUAL DEPTH PERCEPTION |
1 |
0.0012 |
| 157 |
LEUKOCYTURIA |
1 |
0.0012 |
| 158 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 159 |
ASPARTATE AMINOTRANSFERASE INCREASED |
64 |
0.0012 |
| 160 |
CANCER PAIN |
3 |
0.0012 |
| 161 |
DEVICE RELATED INFECTION |
18 |
0.0012 |
| 162 |
THERAPY PARTIAL RESPONDER |
18 |
0.0012 |
| 163 |
TRANSFUSION REACTION |
1 |
0.0011 |
| 164 |
CATHETER SITE PRURITUS |
1 |
0.0011 |
| 165 |
CONJUNCTIVAL HYPERAEMIA |
4 |
0.0011 |
| 166 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 167 |
VENOUS OCCLUSION |
2 |
0.0011 |
| 168 |
TENDON INJURY |
4 |
0.0011 |
| 169 |
DRUG TOLERANCE DECREASED |
3 |
0.0011 |
| 170 |
MICROANGIOPATHY |
1 |
0.0011 |
| 171 |
PROTHROMBIN LEVEL DECREASED |
1 |
0.0011 |
| 172 |
HYPERBILIRUBINAEMIA |
11 |
0.0011 |
| 173 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 174 |
HAEMODYNAMIC INSTABILITY |
8 |
0.0010 |
| 175 |
CANCER SURGERY |
1 |
0.0010 |
| 176 |
CLOSTRIDIUM DIFFICILE COLITIS |
11 |
0.0010 |
| 177 |
ADENOVIRUS INFECTION |
3 |
0.0010 |
| 178 |
MULTI-ORGAN DISORDER |
2 |
0.0010 |
| 179 |
ALANINE AMINOTRANSFERASE INCREASED |
62 |
0.0010 |
| 180 |
HYPERNATRAEMIA |
5 |
0.0010 |
| 181 |
ANORECTAL DISORDER |
2 |
0.0010 |
| 182 |
ANAPHYLACTOID REACTION |
4 |
0.0010 |
| 183 |
CORONAVIRUS TEST POSITIVE |
1 |
0.0010 |
| 184 |
EOSINOPHIL COUNT INCREASED |
8 |
0.0010 |
| 185 |
METASTASES TO PLEURA |
1 |
0.0010 |
| 186 |
EXOPHTHALMOS |
2 |
0.0009 |
| 187 |
URINARY RETENTION |
31 |
0.0009 |
| 188 |
OCULAR TOXICITY |
1 |
0.0009 |
| 189 |
PULMONARY ALVEOLAR HAEMORRHAGE |
5 |
0.0009 |
| 190 |
LOCALISED OEDEMA |
4 |
0.0009 |
| 191 |
HAEMOLYTIC URAEMIC SYNDROME |
2 |
0.0009 |
| 192 |
ACUTE LUNG INJURY |
1 |
0.0008 |
| 193 |
PNEUMONIA INFLUENZAL |
1 |
0.0008 |
| 194 |
MYELODYSPLASTIC SYNDROME |
12 |
0.0008 |
| 195 |
RENAL TUBULAR INJURY |
1 |
0.0008 |
| 196 |
RESPIRATORY DEPRESSION |
10 |
0.0008 |
| 197 |
VENOOCCLUSIVE LIVER DISEASE |
4 |
0.0008 |
| 198 |
CARDIAC DYSFUNCTION |
3 |
0.0008 |
| 199 |
TRISOMY 21 |
1 |
0.0008 |
| 200 |
GLUCOSE URINE PRESENT |
1 |
0.0008 |
| 201 |
NEOPLASM PROGRESSION |
27 |
0.0008 |
| 202 |
SPINAL CORD COMPRESSION |
3 |
0.0008 |
| 203 |
ENCEPHALITIS AUTOIMMUNE |
1 |
0.0008 |
| 204 |
RESPIRATORY DISTRESS |
21 |
0.0008 |
| 205 |
NEUTROPHIL COUNT DECREASED |
31 |
0.0008 |
| 206 |
EXTRADURAL HAEMATOMA |
1 |
0.0008 |
| 207 |
BRONCHIECTASIS |
5 |
0.0007 |
| 208 |
EFFUSION |
1 |
0.0007 |
| 209 |
RHONCHI |
1 |
0.0007 |
| 210 |
VIRAEMIA |
1 |
0.0007 |
| 211 |
PULSELESS ELECTRICAL ACTIVITY |
3 |
0.0007 |
| 212 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 213 |
PNEUMATOSIS INTESTINALIS |
2 |
0.0007 |
| 214 |
METASTATIC NEOPLASM |
3 |
0.0007 |
| 215 |
HORDEOLUM |
3 |
0.0007 |
| 216 |
METASTASES TO LUNG |
8 |
0.0007 |
| 217 |
BONE MARROW FAILURE |
14 |
0.0007 |
| 218 |
C-REACTIVE PROTEIN INCREASED |
25 |
0.0007 |
| 219 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 220 |
IMMUNOSUPPRESSION |
6 |
0.0007 |
| 221 |
STRIDOR |
2 |
0.0007 |
| 222 |
GENITAL PAIN |
1 |
0.0007 |
| 223 |
HISTIOCYTOSIS HAEMATOPHAGIC |
2 |
0.0007 |
| 224 |
PAPILLOEDEMA |
3 |
0.0007 |
| 225 |
ADHESION |
1 |
0.0007 |
| 226 |
SMALL CELL LUNG CANCER |
1 |
0.0007 |
| 227 |
PALLOR |
18 |
0.0007 |
| 228 |
PULMONARY HAEMORRHAGE |
5 |
0.0006 |
| 229 |
URINE KETONE BODY PRESENT |
1 |
0.0006 |
| 230 |
CARDIAC TAMPONADE |
3 |
0.0006 |
| 231 |
BRONCHOSPASM |
9 |
0.0006 |
| 232 |
HYPOKALAEMIA |
29 |
0.0006 |
| 233 |
PNEUMONIA VIRAL |
2 |
0.0006 |
| 234 |
SKULL FRACTURE |
1 |
0.0006 |
| 235 |
INJECTION SITE INFLAMMATION |
3 |
0.0006 |
| 236 |
PANCYTOPENIA |
33 |
0.0006 |
| 237 |
OEDEMA |
32 |
0.0006 |
| 238 |
BACTERAEMIA |
7 |
0.0006 |
| 239 |
PUPIL FIXED |
1 |
0.0006 |
| 240 |
MENTAL STATUS CHANGES |
16 |
0.0006 |
| 241 |
SPLENIC INFARCTION |
1 |
0.0006 |
| 242 |
SERUM FERRITIN INCREASED |
3 |
0.0006 |
| 243 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 244 |
EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0006 |
| 245 |
GENERALISED OEDEMA |
7 |
0.0006 |
| 246 |
PNEUMOMEDIASTINUM |
1 |
0.0006 |
| 247 |
NEURALGIA |
13 |
0.0005 |
| 248 |
HYDRONEPHROSIS |
4 |
0.0005 |
| 249 |
TUNNEL VISION |
1 |
0.0005 |
| 250 |
PHOTOPHOBIA |
10 |
0.0005 |
| 251 |
PROTEIN TOTAL DECREASED |
2 |
0.0005 |
| 252 |
HUMAN HERPESVIRUS 6 INFECTION |
1 |
0.0005 |
| 253 |
PULMONARY HYPERTENSION |
11 |
0.0005 |
| 254 |
GRANULOCYTOPENIA |
3 |
0.0005 |
| 255 |
PROTEINURIA |
10 |
0.0005 |
| 256 |
NEUROLOGICAL SYMPTOM |
3 |
0.0005 |
| 257 |
HEPATIC MASS |
1 |
0.0005 |
| 258 |
TRAUMATIC LUNG INJURY |
1 |
0.0005 |
| 259 |
SINUS BRADYCARDIA |
5 |
0.0005 |
| 260 |
METABOLIC DISORDER |
3 |
0.0005 |
| 261 |
OXYGEN SATURATION DECREASED |
29 |
0.0005 |
| 262 |
PNEUMONIA CYTOMEGALOVIRAL |
1 |
0.0005 |
| 263 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 264 |
PERIPHERAL SENSORY NEUROPATHY |
3 |
0.0005 |
| 265 |
GASTROINTESTINAL INFLAMMATION |
4 |
0.0005 |
| 266 |
LYMPHOCYTE COUNT DECREASED |
9 |
0.0005 |
| 267 |
UNDERWEIGHT |
1 |
0.0005 |
| 268 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
3 |
0.0005 |
| 269 |
BLOOD ALBUMIN DECREASED |
4 |
0.0005 |
| 270 |
PYREXIA |
172 |
0.0005 |
| 271 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 272 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
3 |
0.0005 |
| 273 |
LARYNGEAL OEDEMA |
3 |
0.0005 |
| 274 |
HYPERURICAEMIA |
2 |
0.0005 |
| 275 |
NEUTROPENIC COLITIS |
1 |
0.0005 |
| 276 |
OLIGURIA |
3 |
0.0005 |
| 277 |
BLOOD UREA INCREASED |
8 |
0.0005 |
| 278 |
ASCITES |
14 |
0.0005 |
| 279 |
HALLUCINATIONS, MIXED |
2 |
0.0005 |
| 280 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 281 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 282 |
ABNORMAL SENSATION IN EYE |
2 |
0.0005 |
| 283 |
CLOSTRIDIUM TEST POSITIVE |
1 |
0.0005 |
| 284 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
8 |
0.0005 |
| 285 |
ILEUS PARALYTIC |
2 |
0.0004 |
| 286 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 287 |
METASTASES TO MENINGES |
1 |
0.0004 |
| 288 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 289 |
BREAKTHROUGH PAIN |
1 |
0.0004 |
| 290 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 291 |
METHAEMOGLOBINAEMIA |
1 |
0.0004 |
| 292 |
HYPOMAGNESAEMIA |
6 |
0.0004 |
| 293 |
PULSE ABNORMAL |
1 |
0.0004 |
| 294 |
PLATELET COUNT DECREASED |
44 |
0.0004 |
| 295 |
HYPERCALCAEMIA |
5 |
0.0004 |
| 296 |
TRANSAMINASES INCREASED |
9 |
0.0004 |
| 297 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 298 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 299 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
4 |
0.0004 |
| 300 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
2 |
0.0004 |
| 301 |
ACIDOSIS |
3 |
0.0004 |
| 302 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
1 |
0.0004 |
| 303 |
SARS-COV-2 TEST POSITIVE |
5 |
0.0004 |
| 304 |
AREFLEXIA |
1 |
0.0004 |
| 305 |
TACHYPNOEA |
5 |
0.0004 |
| 306 |
METASTASES TO BONE |
6 |
0.0004 |
| 307 |
RHINALGIA |
1 |
0.0004 |
| 308 |
SERUM SICKNESS |
1 |
0.0004 |
| 309 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 310 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 311 |
PERICARDIAL EFFUSION |
8 |
0.0003 |
| 312 |
ELECTROLYTE IMBALANCE |
4 |
0.0003 |
| 313 |
ABDOMINAL PAIN |
80 |
0.0003 |
| 314 |
SEDATION |
9 |
0.0003 |
| 315 |
HYPERTRIGLYCERIDAEMIA |
2 |
0.0003 |
| 316 |
CREPITATIONS |
1 |
0.0003 |
| 317 |
URINE ANALYSIS ABNORMAL |
1 |
0.0003 |
| 318 |
BLOOD BILIRUBIN INCREASED |
9 |
0.0003 |
| 319 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
1 |
0.0003 |
| 320 |
BONE MARROW DISORDER |
1 |
0.0003 |
| 321 |
THROMBOCYTOPENIA |
37 |
0.0003 |
| 322 |
CRANIOCEREBRAL INJURY |
1 |
0.0003 |
| 323 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 324 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
3 |
0.0003 |
| 325 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 326 |
CONJUNCTIVITIS |
6 |
0.0003 |
| 327 |
BACTERIAL INFECTION |
6 |
0.0003 |
| 328 |
HYPOCALCAEMIA |
6 |
0.0003 |
| 329 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 330 |
PNEUMOTHORAX |
5 |
0.0003 |
| 331 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 332 |
WHITE BLOOD CELL COUNT INCREASED |
12 |
0.0003 |
| 333 |
VITAMIN D DEFICIENCY |
3 |
0.0003 |
| 334 |
HYPOGAMMAGLOBULINAEMIA |
2 |
0.0003 |
| 335 |
ANAEMIA |
58 |
0.0003 |
| 336 |
OTITIS MEDIA |
1 |
0.0003 |
| 337 |
HYPONATRAEMIA |
17 |
0.0003 |
| 338 |
NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL |
1 |
0.0003 |
| 339 |
POTENTIATING DRUG INTERACTION |
1 |
0.0003 |
| 340 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 341 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 342 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 343 |
NEOPLASM RECURRENCE |
1 |
0.0003 |
| 344 |
HYPOTENSION |
59 |
0.0003 |
| 345 |
SUDDEN CARDIAC DEATH |
1 |
0.0003 |
| 346 |
BLOOD CREATININE INCREASED |
19 |
0.0003 |
| 347 |
VENTRICULAR EXTRASYSTOLES |
3 |
0.0003 |
| 348 |
RESPIRATORY FAILURE |
21 |
0.0003 |
| 349 |
DERMATITIS EXFOLIATIVE GENERALISED |
1 |
0.0003 |
| 350 |
PETECHIAE |
3 |
0.0003 |
| 351 |
SINUS TACHYCARDIA |
4 |
0.0003 |
| 352 |
END STAGE RENAL DISEASE |
5 |
0.0003 |
| 353 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 354 |
ACUTE MYELOID LEUKAEMIA |
4 |
0.0003 |
| 355 |
RESPIRATORY ACIDOSIS |
1 |
0.0003 |
| 356 |
HAEMATOCRIT DECREASED |
5 |
0.0003 |
| 357 |
BLEPHARITIS |
1 |
0.0002 |
| 358 |
PLEURAL EFFUSION |
15 |
0.0002 |
| 359 |
SECOND PRIMARY MALIGNANCY |
2 |
0.0002 |
| 360 |
COAGULOPATHY |
4 |
0.0002 |
| 361 |
TACHYCARDIA |
21 |
0.0002 |
| 362 |
LIP OEDEMA |
1 |
0.0002 |
| 363 |
EATING DISORDER |
5 |
0.0002 |
| 364 |
RESPIRATORY DISORDER |
7 |
0.0002 |
| 365 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 366 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 367 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0002 |
| 368 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
2 |
0.0002 |
| 369 |
CLOSTRIDIUM DIFFICILE INFECTION |
5 |
0.0002 |
| 370 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 371 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 372 |
DISEASE PROGRESSION |
26 |
0.0002 |
| 373 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 374 |
BRAIN NEOPLASM |
2 |
0.0002 |
| 375 |
SHOCK |
5 |
0.0002 |
| 376 |
PAIN IN JAW |
6 |
0.0002 |
| 377 |
HAEMATOTOXICITY |
2 |
0.0002 |
| 378 |
PULSE ABSENT |
1 |
0.0002 |
| 379 |
HYPOVOLAEMIC SHOCK |
1 |
0.0002 |
| 380 |
RASH VESICULAR |
1 |
0.0002 |
| 381 |
HYPOKINESIA |
3 |
0.0002 |
| 382 |
COMPLICATION ASSOCIATED WITH DEVICE |
3 |
0.0002 |
| 383 |
GASTROENTERITIS |
3 |
0.0002 |
| 384 |
LIVER INJURY |
5 |
0.0002 |
| 385 |
HEPATOMEGALY |
2 |
0.0002 |
| 386 |
WHEEZING |
12 |
0.0002 |
| 387 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 388 |
BLADDER DISORDER |
2 |
0.0002 |
| 389 |
IMMUNODEFICIENCY |
3 |
0.0002 |
| 390 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 391 |
HYPOTONIA |
2 |
0.0002 |
| 392 |
OSTEOPENIA |
3 |
0.0002 |
| 393 |
BLINDNESS |
8 |
0.0002 |
| 394 |
PRODUCT USE IN UNAPPROVED INDICATION |
46 |
0.0002 |
| 395 |
STRESS FRACTURE |
1 |
0.0002 |
| 396 |
BEHAVIOUR DISORDER |
1 |
0.0002 |
| 397 |
PNEUMONITIS |
5 |
0.0002 |
| 398 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 399 |
PULMONARY OEDEMA |
8 |
0.0002 |
| 400 |
ACUTE PULMONARY OEDEMA |
1 |
0.0002 |
| 401 |
THERAPY NON-RESPONDER |
8 |
0.0002 |
| 402 |
STATUS EPILEPTICUS |
2 |
0.0002 |
| 403 |
ENTEROCOLITIS |
1 |
0.0002 |
| 404 |
BLOOD URIC ACID INCREASED |
1 |
0.0002 |
| 405 |
PAIN IN EXTREMITY |
51 |
0.0002 |
| 406 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
2 |
0.0002 |
| 407 |
HYPERKALAEMIA |
6 |
0.0002 |
| 408 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 409 |
INGUINAL HERNIA |
1 |
0.0002 |
| 410 |
ENCEPHALOPATHY |
4 |
0.0002 |
| 411 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 412 |
LIVER DISORDER |
7 |
0.0002 |
| 413 |
HYPOTHYROIDISM |
5 |
0.0002 |
| 414 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 415 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 416 |
DIPLOPIA |
4 |
0.0002 |
| 417 |
DEAFNESS |
4 |
0.0002 |
| 418 |
URTICARIA |
25 |
0.0001 |
| 419 |
CONSTIPATION |
32 |
0.0001 |
| 420 |
PAIN |
90 |
0.0001 |
| 421 |
CARDIAC ARREST |
12 |
0.0001 |
| 422 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 423 |
VOMITING |
68 |
0.0001 |
| 424 |
HYPOGLYCAEMIA |
7 |
0.0001 |
| 425 |
WEIGHT INCREASED |
32 |
0.0001 |
| 426 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 427 |
DISSEMINATED INTRAVASCULAR COAGULATION |
2 |
0.0001 |
| 428 |
METASTASIS |
1 |
0.0001 |
| 429 |
NEUTROPENIC SEPSIS |
1 |
0.0001 |
| 430 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 431 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 432 |
MYELOSUPPRESSION |
5 |
0.0001 |
| 433 |
ALTERED STATE OF CONSCIOUSNESS |
3 |
0.0001 |
| 434 |
TONGUE DISORDER |
1 |
0.0001 |
| 435 |
FLUID OVERLOAD |
2 |
0.0001 |
| 436 |
RASH MACULO-PAPULAR |
3 |
0.0001 |
| 437 |
OFF LABEL USE |
116 |
0.0001 |
| 438 |
LIPASE INCREASED |
1 |
0.0001 |
| 439 |
HAEMOLYSIS |
1 |
0.0001 |
| 440 |
APNOEA |
1 |
0.0001 |
| 441 |
HYPERTENSION |
27 |
0.0001 |
| 442 |
ANAPHYLACTIC REACTION |
7 |
0.0001 |
| 443 |
COUGH |
35 |
0.0001 |
| 444 |
MIOSIS |
1 |
0.0001 |
| 445 |
SENSORY LOSS |
1 |
0.0001 |
| 446 |
RHINITIS |
1 |
0.0001 |
| 447 |
STAPHYLOCOCCAL INFECTION |
4 |
0.0001 |
| 448 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
3 |
0.0001 |
| 449 |
INFUSION RELATED REACTION |
8 |
0.0001 |
| 450 |
FEBRILE NEUTROPENIA |
8 |
0.0001 |
| 451 |
BLOOD PRESSURE DECREASED |
8 |
0.0001 |
| 452 |
EPISTAXIS |
9 |
0.0001 |
| 453 |
PNEUMONIA ASPIRATION |
3 |
0.0001 |
| 454 |
FACIAL PARALYSIS |
1 |
0.0001 |
| 455 |
HAEMATURIA |
4 |
0.0001 |
| 456 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 457 |
VISION BLURRED |
16 |
0.0001 |
| 458 |
NEUROPATHY PERIPHERAL |
11 |
0.0001 |
| 459 |
CARDIAC MURMUR |
1 |
0.0001 |
| 460 |
THIRST |
2 |
0.0001 |
| 461 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 462 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 463 |
TREATMENT FAILURE |
9 |
0.0001 |
| 464 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 465 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 466 |
RENAL IMPAIRMENT |
9 |
0.0001 |
| 467 |
NEPHROPATHY |
1 |
0.0001 |
| 468 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 469 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
3 |
0.0001 |
| 470 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 471 |
DEHYDRATION |
14 |
0.0001 |
| 472 |
CHOLESTASIS |
2 |
0.0001 |
| 473 |
DYSSTASIA |
3 |
0.0001 |
| 474 |
BONE PAIN |
6 |
0.0001 |
| 475 |
THERAPY CHANGE |
1 |
0.0001 |
| 476 |
LEUKOPENIA |
5 |
0.0001 |
| 477 |
BRAIN INJURY |
1 |
0.0001 |
| 478 |
CYTOKINE RELEASE SYNDROME |
2 |
0.0001 |
| 479 |
FULL BLOOD COUNT DECREASED |
2 |
0.0001 |
| 480 |
FEEDING DISORDER |
2 |
0.0001 |
| 481 |
EYELID PTOSIS |
1 |
0.0001 |
| 482 |
EAR DISCOMFORT |
1 |
0.0001 |
| 483 |
NEUTROPENIA |
13 |
0.0001 |
| 484 |
TRANSFUSION |
1 |
0.0001 |
| 485 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 486 |
HYPOACUSIS |
4 |
0.0001 |
| 487 |
HALLUCINATION |
7 |
0.0001 |
| 488 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 489 |
SEPTIC SHOCK |
4 |
0.0001 |
| 490 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 491 |
ANGIOEDEMA |
4 |
0.0001 |
| 492 |
DECREASED APPETITE |
21 |
0.0001 |
| 493 |
VISUAL ACUITY REDUCED |
3 |
0.0001 |
| 494 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 495 |
NECK PAIN |
5 |
0.0001 |
| 496 |
MALNUTRITION |
1 |
0.0001 |
| 497 |
CARDIAC FAILURE |
7 |
0.0001 |
| 498 |
SPINAL PAIN |
1 |
0.0001 |
| 499 |
MYOCLONUS |
1 |
0.0001 |
| 500 |
IRRITABILITY |
5 |
0.0001 |
| 501 |
PRESYNCOPE |
2 |
0.0001 |
| 502 |
CYTOPENIA |
1 |
0.0001 |
| 503 |
DYSURIA |
3 |
0.0001 |
| 504 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 505 |
ILEUS |
1 |
0.0001 |
| 506 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 507 |
FLUID RETENTION |
4 |
0.0001 |
| 508 |
HEPATIC CYTOLYSIS |
1 |
0.0001 |
| 509 |
ACUTE KIDNEY INJURY |
12 |
0.0001 |
| 510 |
HYPOPHAGIA |
2 |
0.0001 |
| 511 |
DIARRHOEA |
50 |
0.0001 |
| 512 |
CHILLS |
9 |
0.0001 |
| 513 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
3 |
0.0001 |
| 514 |
MALAISE |
33 |
0.0001 |
| 515 |
COVID-19 |
13 |
0.0001 |
| 516 |
MOOD ALTERED |
2 |
0.0001 |
| 517 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 518 |
RESPIRATORY ARREST |
2 |
0.0001 |
| 519 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 520 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 521 |
LYMPHOPENIA |
1 |
0.0001 |
| 522 |
PARALYSIS |
1 |
0.0001 |
| 523 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 524 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 525 |
HAEMOGLOBIN DECREASED |
7 |
0.0001 |
| 526 |
RENAL FAILURE |
9 |
0.0001 |
| 527 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 528 |
STOMATITIS |
4 |
0.0001 |
| 529 |
NAUSEA |
52 |
0.0001 |
| 530 |
WHITE BLOOD CELL COUNT DECREASED |
7 |
0.0001 |
| 531 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 532 |
DISEASE RECURRENCE |
3 |
0.0001 |
| 533 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 534 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 535 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 536 |
MUSCULAR WEAKNESS |
7 |
0.0001 |
| 537 |
VENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 538 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 539 |
VIRAL INFECTION |
2 |
0.0001 |
| 540 |
FUNGAL INFECTION |
2 |
0.0001 |
| 541 |
AGGRESSION |
3 |
0.0001 |
| 542 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 543 |
CHEST PAIN |
11 |
0.0001 |
| 544 |
CANDIDA INFECTION |
1 |
0.0001 |
| 545 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 546 |
PNEUMONIA |
19 |
0.0001 |
| 547 |
MALIGNANT NEOPLASM PROGRESSION |
6 |
0.0001 |
| 548 |
NEUROTOXICITY |
1 |
0.0001 |
| 549 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 550 |
BRADYCARDIA |
3 |
0.0001 |
| 551 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 552 |
DRUG ERUPTION |
1 |
0.0001 |
| 553 |
BACK PAIN |
13 |
0.0001 |
| 554 |
CONFUSIONAL STATE |
9 |
0.0001 |
| 555 |
INFECTION |
8 |
0.0001 |
| 556 |
SEPSIS |
6 |
0.0001 |
| 557 |
TUBULOINTERSTITIAL NEPHRITIS |
1 |
0.0001 |
| 558 |
EYE PAIN |
3 |
0.0001 |
| 559 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 560 |
COLITIS |
2 |
0.0001 |
| 561 |
LETHARGY |
3 |
0.0001 |
| 562 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 563 |
DRUG PRESCRIBING ERROR |
1 |
0.0001 |
| 564 |
SEIZURE |
6 |
0.0001 |
| 565 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 566 |
ORAL HERPES |
1 |
0.0001 |
| 567 |
DYSPEPSIA |
5 |
0.0001 |
| 568 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 569 |
HYPERSENSITIVITY |
9 |
0.0000 |
| 570 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 571 |
HEADACHE |
30 |
0.0000 |
| 572 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 573 |
ORAL PAIN |
1 |
0.0000 |
| 574 |
RASH PAPULAR |
1 |
0.0000 |
| 575 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 576 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 577 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 578 |
SOMNOLENCE |
8 |
0.0000 |
| 579 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 580 |
HAEMATEMESIS |
1 |
0.0000 |
| 581 |
WEIGHT DECREASED |
11 |
0.0000 |
| 582 |
DRUG RESISTANCE |
1 |
0.0000 |
| 583 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 584 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 585 |
RASH GENERALISED |
1 |
0.0000 |
| 586 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 587 |
MUSCULOSKELETAL PAIN |
2 |
0.0000 |
| 588 |
DRUG INTERACTION |
6 |
0.0000 |
| 589 |
JAUNDICE |
1 |
0.0000 |
| 590 |
RASH |
16 |
0.0000 |
| 591 |
GAIT DISTURBANCE |
7 |
0.0000 |
| 592 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 593 |
HAEMOPTYSIS |
1 |
0.0000 |
| 594 |
WOUND |
1 |
0.0000 |
| 595 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 596 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 597 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 598 |
FATIGUE |
26 |
0.0000 |
| 599 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 600 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 601 |
EPILEPSY |
1 |
0.0000 |
| 602 |
INJECTION SITE RASH |
1 |
0.0000 |
| 603 |
CARDIAC DISORDER |
3 |
0.0000 |
| 604 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 605 |
RHINORRHOEA |
2 |
0.0000 |
| 606 |
CHOLELITHIASIS |
1 |
0.0000 |
| 607 |
EYE DISORDER |
1 |
0.0000 |
| 608 |
SYNCOPE |
3 |
0.0000 |
| 609 |
NEOPLASM MALIGNANT |
2 |
0.0000 |
| 610 |
ABDOMINAL DISCOMFORT |
5 |
0.0000 |
| 611 |
EYE PRURITUS |
1 |
0.0000 |
| 612 |
ANGER |
1 |
0.0000 |
| 613 |
PRURITUS |
11 |
0.0000 |
| 614 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 615 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 616 |
MOBILITY DECREASED |
2 |
0.0000 |
| 617 |
CRYING |
1 |
0.0000 |
| 618 |
EYE SWELLING |
1 |
0.0000 |
| 619 |
HYPOAESTHESIA |
4 |
0.0000 |
| 620 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 621 |
ARTHRALGIA |
11 |
0.0000 |
| 622 |
GENERAL PHYSICAL HEALTH DETERIORATION |
3 |
0.0000 |
| 623 |
DISORIENTATION |
1 |
0.0000 |
| 624 |
ANXIETY |
7 |
0.0000 |
| 625 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 626 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 627 |
DRY SKIN |
3 |
0.0000 |
| 628 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 629 |
RENAL DISORDER |
1 |
0.0000 |
| 630 |
MIGRAINE |
2 |
0.0000 |
| 631 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 632 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 633 |
LUNG DISORDER |
1 |
0.0000 |
| 634 |
HEART RATE INCREASED |
2 |
0.0000 |
| 635 |
FLUSHING |
2 |
0.0000 |
| 636 |
THERAPY CESSATION |
1 |
0.0000 |
| 637 |
DYSPNOEA |
11 |
0.0000 |
| 638 |
ILLNESS |
2 |
0.0000 |
| 639 |
INFLAMMATION |
1 |
0.0000 |
| 640 |
ECZEMA |
1 |
0.0000 |
| 641 |
SPEECH DISORDER |
1 |
0.0000 |
| 642 |
DRUG INEFFECTIVE |
25 |
0.0000 |
| 643 |
PANCREATITIS |
1 |
0.0000 |
| 644 |
DEPRESSED MOOD |
1 |
0.0000 |
| 645 |
ASTHENIA |
7 |
0.0000 |
| 646 |
RASH PRURITIC |
1 |
0.0000 |
| 647 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 648 |
INFLUENZA |
2 |
0.0000 |
| 649 |
ASTHMA |
2 |
0.0000 |
| 650 |
DYSPHONIA |
1 |
0.0000 |
| 651 |
NASAL CONGESTION |
1 |
0.0000 |
| 652 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 653 |
FEELING HOT |
1 |
0.0000 |
| 654 |
DEEP VEIN THROMBOSIS |
1 |
0.0000 |
| 655 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 656 |
DEATH |
13 |
0.0000 |
| 657 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 658 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 659 |
SLEEP DISORDER |
1 |
0.0000 |
| 660 |
AGITATION |
1 |
0.0000 |
| 661 |
DYSGEUSIA |
1 |
0.0000 |
| 662 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 663 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 664 |
TREMOR |
2 |
0.0000 |
| 665 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 666 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 667 |
MYALGIA |
2 |
0.0000 |
| 668 |
MYOCARDIAL INFARCTION |
2 |
0.0000 |
| 669 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 670 |
SWELLING |
1 |
0.0000 |
| 671 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 672 |
DYSPHAGIA |
1 |
0.0000 |
| 673 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 674 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 675 |
SINUSITIS |
1 |
0.0000 |
| 676 |
FEELING ABNORMAL |
2 |
0.0000 |
| 677 |
JOINT SWELLING |
1 |
0.0000 |
| 678 |
INSOMNIA |
2 |
0.0000 |
| 679 |
CONDITION AGGRAVATED |
2 |
0.0000 |
| 680 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 681 |
PARAESTHESIA |
1 |
0.0000 |
| 682 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 683 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 684 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 685 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 686 |
ERYTHEMA |
1 |
0.0000 |
| 687 |
OVERDOSE |
1 |
0.0000 |
| 688 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 689 |
FALL |
1 |
0.0000 |
| 690 |
DIZZINESS |
1 |
0.0000 |